Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tychan Completes Human Safety Studies for Monoclonal Antibody against Zika

americanpharmaceuticalreviewOctober 30, 2018

Tag: Tychan , monoclonal antibody , Zika , Tyzivumab

PharmaSources Customer Service